65 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
incentive plans described in, the Registration Statement, the Pricing Disclosure Package and the Prospectus), short-term debt or long-term debt … as an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), so qualifies, (ii) each grant
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
compensation plans, consisting of (i) 705,607 shares of common stock reserved for future issuance under our 2020 Equity Incentive Plan (2020 Plan … that may be granted under our equity incentive plans, and when we otherwise issue additional shares of our common stock. Furthermore, if any of our
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
plans, consisting of (i) 705,607 shares of common stock reserved for future issuance under our 2020 Equity Incentive Plan (2020 Plan), as of February 29 … equity incentive plans, and when we otherwise issue additional shares of our common stock. Furthermore, if any of our outstanding pre-funded warrants
S-8
7foi9xer3 92f
15 Feb 24
Registration of securities for employees
4:51pm
S-8
EX-5.1
axy1pfvqdtvjjx
15 Feb 24
Registration of securities for employees
4:51pm
S-8
5tnfof8twe92nqtwu1
15 Feb 24
Registration of securities for employees
4:51pm
8-K
qaakqdzvl
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
8-K
EX-10.1
6e2vss7 ryp
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
i896pa6gx306ikdr854y
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
nfhd6xetuexu7y
8 Jul 22
Prospectus supplement for primary offering
4:09pm